Abstract:The rates of overweight and obesity around the world have increased in past years. The body adipose tissue stimulates the antioxidant and oxidizing unbalance capacity at the cellular level. This scenario favors an inflammatory low-grade systemic condition starting with insulin resistance, which in turn may involve diabetes mellitus type 2 and cognitive decline afterward. Neurological diseases have been correlated to senile ages diseases over time. This scenario calls for a change in the incidence of obesity in the younger. An unhealthy dietary consumption together with sedentary habits might lead to poor gut absorption of nutrients. Several plants and foods have bioactive compounds that can reduce or inhibit radical scavengers, reactive oxygen species, and metal ion complexes that threaten the cerebral defense system. The bitter acids from hops (Humulus lupulus L.) have been demonstrated promising effects on lipid and carbohydrate metabolism improvement, and reducing inflammatory responses through alpha acids, beta acids, and analogs action. Therefore, the current study aimed to investigate the bioactivity of hop bitter acids in obese and lean mice. For that, a dry hop extract (DHE) obtained was applying carbon dioxide as the fluid of supercritical extraction. Afterward, seventy-eight male mice of the C57/JB6 strain were weighed and randomly distributed into six groups of 13 animals each according to the diet offered: (NO) normolipidic diet, (NO1) normolipidic diet containing 0.35% alpha acids, (NO2) normolipidic diet containing 3.5% alpha acids, (HP) hyperlipidic diet (HP1) hyperlipidic diet containing 0.35% alpha acids, and (HP2) hyperlipidic diet containing 3.5% alpha acids. After applying the glycemic tolerance and insulin tolerance tests, were observed a better stabilization of glycemia levels and weight gain among those animals fed with DHE (NO2 and HP2), in comparison to the obese control group (HP) (p < 0.05). There was also an amelioration of antioxidant capacity observed by checking the enzymatic profile by SOD and an apparent mitigation of brain degeneration by checking GSK3β and p-IRS1 proteins expression (p < 0.05). The y-maze cognitive test applied to highlight possible obesity-harmfulon animal brains did not indicate a statistical difference between the groups. Although the weekly dietary intake between the obese HP2 group (33.32 ± 4.11, p < 0.05) and control HP (42.3 ± 5.88, p <0.05) was different. The bioactive compounds present in DHE have demonstrated relevant effects to glycemic control, insulin signaling, and the consequent modulatory action of obesity- related markers with the brain's inflammatory progression.

Hop Phytochemicals and Their Potential Role in Metabolic Syndrome Prevention and Therapy

The Multiple Biological Targets of Hops and Bioactive Compounds

Hop Compounds: Extraction Techniques, Chemical Analyses, Antioxidative, Antimicrobial, and Anticarcinogenic Effects

An Updated Review of the Genus Humulus: A Valuable Source of Bioactive Compounds for Health and Disease Prevention

Humulus lupulus L.: Evaluation of Phytochemical Profile and Activation of Bitter Taste Receptors to Regulate Appetite and Satiety in Intestinal Secretin Tumor Cell Line (STC-1 Cells)

Pharmacological Profile of Xanthohumol, a Prenylated Flavonoid from Hops (humulus Lupulus)

Hop (Humulus lupulus L.) extract reverts glycaemic imbalance and cognitive impairment on an animal model of obesity

Predicting concentrations of dietary hop phytoestrogens by physiologically based kinetic modeling

Xanthohumol for Human Malignancies: Chemistry, Pharmacokinetics and Molecular Targets

Isolation and Identification of Prenylflavonoids from Humulus Lupulus

Exploring Two Types of Prenylated Bitter Compounds from Hop Plant (humulus Lupulus L.) Against Α-Glucosidase in Vitro and in Silico.

Proanthocyanidins In Hops

Research Progress in Biological Activity and Quantitative Analysis of Plant Estrogen 8-PN in Hops

Humulus lupulus L. as a Natural Source of Functional Biomolecules

Xanthohumol, a Prenylated Chalcone from Beer Hops, Acts As an Α-Glucosidase Inhibitor in Vitro

Comprehensive Insights into the Versatile Benefits of Hop Extracts

Hop leaves: From waste to a valuable source of bioactive compounds - A multidisciplinary approach to investigating potential applications

Effect of Dietary Purified Xanthohumol from Hop (Humulus lupulus L.) Pomace on Adipose Tissue Mass, Fasting Blood Glucose Level, and Lipid Metabolism in KK-Ay Mice

Systemically Achievable Doses of Beer Flavonoids Induce Estrogenicity in Human Endometrial Cells and Cause Synergistic Effects With Selected Pesticides

The Hop Polyphenols Xanthohumol and 8-Prenyl-Naringenin Antagonize the Estrogenic Effects of Fusarium Mycotoxins in Human Endometrial Cancer Cells

DESIGNER Extracts as Tools to Balance Estrogenic and Chemopreventive Activities of Botanicals for Women’s Health